Sterility Assurance practices will need to pivot with a focus on the Microbiological Quality of future products. This means that the sterility assurance community may need to think differently with new innovative products and how we deliver microbiological quality. In addition, the development of new emerging leaders needs to continue to be a priority for the technical community. The industry must focus on providing these leaders with key experiences – both technical and management – to develop the competencies needed to support innovations. The first part of this presentation will share information on what product microbiological quality means and future changes, and the second part of this presentation will focus on cultivating emerging leaders.